Abc Borderline Resectable Pancreatic Cancer clinical trials

Explore recruiting abc borderline resectable pancreatic cancer clinical trials.

Also recruiting in Europe

Abc Borderline Resectable Pancreatic Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A national randomised multi-centre phase II/III trial using MesoPher in ABC borderline resectable pancreatic cancer (PREOPANC-6 trial)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Abc Borderline Resectable Pancreatic Cancer trials by city

Abc Borderline Resectable Pancreatic Cancer in Toronto Abc Borderline Resectable Pancreatic Cancer in Vancouver Abc Borderline Resectable Pancreatic Cancer in Montreal Abc Borderline Resectable Pancreatic Cancer in Calgary Abc Borderline Resectable Pancreatic Cancer in Edmonton Abc Borderline Resectable Pancreatic Cancer in Ottawa Abc Borderline Resectable Pancreatic Cancer in Winnipeg Abc Borderline Resectable Pancreatic Cancer in Quebec City Abc Borderline Resectable Pancreatic Cancer in Hamilton Abc Borderline Resectable Pancreatic Cancer in Kitchener Abc Borderline Resectable Pancreatic Cancer in London Abc Borderline Resectable Pancreatic Cancer in Halifax Abc Borderline Resectable Pancreatic Cancer in New York Abc Borderline Resectable Pancreatic Cancer in Los Angeles Abc Borderline Resectable Pancreatic Cancer in Chicago Abc Borderline Resectable Pancreatic Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease